dimercaprol

There may be other drugs that can interact with dimercaprol.

Your doctor or pharmacist can provide more information about dimercaprol.

The treatment for lead poisoning consists of dimercaprol and succimer.

Follow your doctor's instructions about any restrictions on food, beverages, or activity after you are treated with dimercaprol.

Since dimercaprol is given as needed by a healthcare professional, it is not likely that you will miss a dose.

It is not known whether dimercaprol passes into breast milk or if it could harm a nursing baby.

It is effectively treated with British anti-lewisite (dimercaprol).

Gold toxicity can be ameliorated with chelation therapy with an agent such as dimercaprol.

People receiving dimercaprol need to be assessed for peanut allergies since the commercial formulation contains peanut oil.

In an emergency situation, it may not be possible before you are treated with dimercaprol to tell your caregivers if you are pregnant or breast-feeding.

Calcium EDTA is also effective if administered four hours after the administration of dimercaprol.

Her sweat glands excrete dimercaprol and chloramine to counteract blistering agents such as mustard gas.

It has been suggested that chelation agents such as British Anti-Lewisite (dimercaprol) can be used to decontaminate humans.

The mortality in reported cases is high, varying between 35% and 42% despite intensive supportive treatment in conjunction with the use of antibiotics, steroids, and dimercaprol.

Administering dimercaprol prior to calcium EDTA is necessary to prevent the redistribution of lead into the central nervous system.

In cases of suspected copper poisoning, penicillamine is the drug of choice, and dimercaprol, a heavy metal chelating agent, is often administered.

In rare cases where none of the oral treatments are effective, especially in severe neurological disease, dimercaprol (British anti-Lewisite) is occasionally necessary.

If possible, before you receive dimercaprol, tell your doctor if you are allergic to any drugs, or if you have liver or kidney disease.

If you have any of these conditions, you may not be able to receive dimercaprol, or you may need a dose or special tests to safely receive this medication.

Although treatment with dimercaprol will increase the excretion of cadmium, there is a concomitant increase in renal cadmium concentration, so that its use in case of cadmium toxicity is to be avoided.

The chelating agents used for treatment of lead poisoning are edetate disodium calcium (CaNaEDTA), dimercaprol (BAL), which are injected, and succimer and d-penicillamine, which are administered orally.